TIAN RUIXIANG Unveils Groundbreaking Artificial Intelligence Initiative with Top Insurance Firms, expecting USD 4 billion revenue increment at 300% growth annually to Redefine Enterprise Innovation Across insurance broker industry

Rhea-AI Summary

Tian Ruixiang Holdings (NASDAQ: TIRX) announced the TIRX AI Strategic Initiative on February 4, 2026, a multi‑billion‑dollar ecosystem targeting insurance and broker firms with generative AI, predictive analytics, autonomous operations and healthcare intelligence.

The company cites custom LLMs, automation of up to 90% routine work, claimed 40% operational cost reductions, a healthcare suite with 95% accuracy, and analyst projections of 300% YoY AI revenue growth by 2027.

Positive

• Projected 300% YoY AI-related revenue growth by 2027
• 90% automation of routine knowledge work via custom LLMs
• 40% operational cost reduction claimed from autonomous operations platform

Negative

• None.

News Market Reaction

-16.27%

23 alerts

-16.27% News Effect

+2.5% Peak Tracked

-42.0% Trough Tracked

-$2M Valuation Impact

$13M Market Cap

0.6x Rel. Volume

On the day this news was published, TIRX declined 16.27%, reflecting a significant negative market reaction. Argus tracked a peak move of +2.5% during that session. Argus tracked a trough of -42.0% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $13M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Projected revenue increase: USD 4 billion Revenue growth: 300% annually AI revenue growth by 2027: 300% year-over-year +4 more

7 metrics

Projected revenue increase USD 4 billion Expected revenue increment from AI initiative

Revenue growth 300% annually Projected AI-related growth mentioned in headline/body

AI revenue growth by 2027 300% year-over-year Analysts’ projection for AI-related revenue by 2027

Healthcare suite accuracy 95% accuracy AI-powered Healthcare Intelligence Suite precision medicine outcomes

Routine work automation 90% of routine knowledge work Capability of TIRX generative AI foundation models

Operational cost reduction 40% reduction Autonomous Operations Platform targeted cost savings

Targeted GDP pool $20 trillion Industries’ global GDP targeted for AI solutions

Market Reality Check

Price: $0.1150 Vol: Volume 1,244,655,962 is 1...

high vol

$0.1150 Last Close

Volume Volume 1,244,655,962 is 13.77x the 20-day average of 90,393,784, signaling extreme trading interest ahead of this AI initiative. high

Technical Despite the 98.41% move to $0.15, shares remain below the 200-day MA of $3.40 and 98.6% under the 52-week high of $10.75.

Peers on Argus

TIRX gained 98.41% while key insurance broker peers mostly slipped modestly (e.g...

TIRX gained 98.41% while key insurance broker peers mostly slipped modestly (e.g., AIFU -1.97%, EHTH -4.68%, XHG -2.70%), with only GOCO and ZBAO slightly up (0.46%, 0.82%). The move appears stock-specific rather than sector-driven.

Historical Context

5 past events · Latest: Feb 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 03	AI-crypto partnership	Positive	+98.4%	Strategic deal to receive 15,000 BTC and build joint AI-crypto lab.
Jan 30	AI broker acquisition	Positive	-21.8%	Planned acquisition of high-growth AI- and crypto-enabled insurance broker.
Jan 28	Strategic investment MOU	Positive	+311.2%	Non-binding SwiftStart MOU for $80M equity investment at $1.50 per share.
Jan 26	Nasdaq delisting notice	Negative	-12.6%	Nasdaq determination to delist after bid-price noncompliance despite appeal.
Nov 07	Ren Talents acquisition	Positive	-7.1%	Share-based acquisition of Ren Talents to support US and Europe expansion.

Pattern Detected

Recent news shows very large upside reactions to funding/strategic investment headlines, while acquisition and delisting-related announcements have often seen negative follow-through.

Recent Company History

Over the last few months, TIRX has issued a series of transformational announcements. On Nov 5, 2025 and Nov 7, 2025, it agreed to acquire Ren Talents and other businesses using share-based deals. In Jan 2026, Nasdaq minimum bid-price noncompliance and a delisting notice pressured the stock. A planned SwiftStart investment of $80 million then coincided with a 311.21% move, and a massive 15,000 BTC AI-crypto partnership on Feb 3, 2026 saw another 98.41% jump. Today’s AI initiative continues this pattern of ambitious, balance-sheet and technology-focused pivots.

Market Pulse Summary

The stock dropped -16.3% in the session following this news. A negative reaction despite optimistic ...

Analysis

The stock dropped -16.3% in the session following this news. A negative reaction despite optimistic AI projections would fit a pattern where markets occasionally discount aggressive growth narratives and acquisition plans, as seen after earlier deals. Past financing activity and Nasdaq compliance issues have created overhangs that can overshadow positive-sounding strategy. If shares sold off, it would highlight concern about execution, potential dilution from prior offerings, and the gap between bold targets like $4 billion added revenue and the current $3.3 million market capitalization.

Key Terms

large language models, generative ai, predictive analytics, autonomous systems, +1 more

5 terms

large language models technical

"Custom-trained large language models (LLMs) optimized for insurance use cases"

Large language models are advanced AI systems trained on vast amounts of text to understand and generate human-like writing, like a very fast reader and writer that learns patterns in words and sentences. They matter to investors because they can change how companies operate—automating customer service, speeding analysis, cutting costs, creating new products—and they introduce risks around accuracy, security and regulation that can affect a firm’s revenue and reputation.

generative ai technical

"become a global powerhouse in generative AI, predictive analytics, and autonomous systems"

Generative AI is a type of computer technology that can create new content, like text, images, or music, on its own. It’s important because it can produce realistic and useful material quickly, which could change how we create art, write stories, or even develop new products. Think of it as a smart robot that can invent and produce things almost like a human.

predictive analytics technical

"global powerhouse in generative AI, predictive analytics, and autonomous systems"

Predictive analytics uses historical data and patterns to estimate future outcomes, like sales, customer behavior, or operational problems. For investors it matters because it turns past signals into probable forecasts—similar to a weather forecast or traffic app—helping assess potential risks, spot opportunities, and prioritize where to allocate capital, while remembering that predictions carry uncertainty and are not guarantees.

autonomous systems technical

"global powerhouse in generative AI, predictive analytics, and autonomous systems"

Autonomous systems are machines or technology that can operate and make decisions on their own, without needing constant human guidance. They use sensors, software, and rules to perform tasks independently, much like a self-driving car navigating traffic. For investors, understanding autonomous systems is important because they are transforming industries, increasing efficiency, and creating new opportunities for innovation and growth.

genomic sequencing medical

"integrates real-time patient data, genomic sequencing, and global medical research"

Genomic sequencing is the process of reading the exact order of the DNA building blocks that make up an organism’s complete genetic instruction manual, like decoding every letter in a very long book. For investors, it matters because that decoded information drives new diagnostics, targeted drugs, and personalized treatments, shaping which biotech products reach the market, how companies compete, and the size and timing of potential revenues or partnerships.

AI-generated analysis. Not financial advice.

Beijing, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited (“Tianruixiang” or the “Company”) (NASDAQ: TIRX), today announced the launch of its highly-anticipated Artificial Intelligence (“AI”) Strategic Initiative—a transformative, multi-billion-dollar ecosystem set to revolutionize insurance enterprises and leverage artificial intelligence to drive exponential growth, operational supremacy, and market dominance. This landmark move underscores TIRX’s aggressive pivot to become a global powerhouse in generative AI, predictive analytics, and autonomous systems, marking the most ambitious technological expansion in the Company’s history.

“The era of incremental AI progress is over. Tianruixiang is here to ignite a revolution,” declared the CEO of Tian Ruixiang Holdings Limited. “With our TIRX AI Strategic Initiative, we are not just entering the AI race—we are building the finish line. We will deploy cutting-edge generative AI models, real-time predictive analytics engines, and autonomous workflow platforms that will redefine productivity, unlock trillions in latent value, and render legacy business operations obsolete. This is not an evolution; it is a technological coup.”

A New Era of AI Dominance: The TIRX AI Strategic Initiative

The TIRX AI Strategic Initiative is a full-spectrum ecosystem designed to deliver unprecedented competitive advantage across high-growth insurance and broker sectors, Key components include:

- TIRX Generative AI Foundation Models: Custom-trained large language models (LLMs) optimized for insurance use cases, capable of automating 90% of routine knowledge work and generating actionable insights from petabytes of unstructured data.

- Autonomous Operations Platform: An end-to-end AI orchestration system that enables zero-human-intervention, self-optimizing, and predictive maintenance protocols that reduce operational costs by 40% or more.

- AI-Powered Healthcare Intelligence Suite: A diagnostic and treatment optimization platform that integrates real-time patient data, genomic sequencing, and global medical research to deliver precision medicine outcomes with 95% accuracy.

Aggressive Execution, Unmatched Expertise

To fuel this initiative, TIRX is in talks with strategic partnerships with top-tier cloud providers and AI infrastructure leaders, ensuring global scalability and hyper-speed deployment. The Company’s technical leadership, which boasts decades of breakthrough AI research, has already delivered industry-first prototypes that outperform competing solutions in accuracy, latency, and cost efficiency.

A Catalyst for Explosive Growth

The launch of the TIRX AI Strategic Initiative is expected to be a seismic catalyst for the Company’s financial performance, with analysts projecting a 300% year-over-year increase in AI-related revenue by 2027. By targeting industries responsible for $20 trillion in global GDP, TIRX is positioned to capture a dominant share of the insurance AI market opportunity by 2030.
“Today, we cross the threshold from industrial leader to AI titan,” added the CEO. “TIRX is not just a stock—it’s a ticket to the future of technology. For investors, partners, and enterprises alike, the message is clear: join us, or be left behind.”

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategic initiatives, financial projections, and market position. These statements are based on current expectations and assumptions, which are subject to risks and uncertainties that could cause actual results to differ materially. For more information, please refer to the Company’s filings with the U.S. Securities and Exchange Commission.

For investor and media enquiries, please contact:

TIAN RUIXIANG Holdings Ltd
Investor Relations Department
Email: ir@tianrx.com

FAQ

What did Tian Ruixiang (TIRX) announce on February 4, 2026 about its AI initiative?

They launched the TIRX AI Strategic Initiative, a multi‑billion‑dollar ecosystem for insurance and brokers. According to the company, it includes custom LLMs, autonomous operations, and a healthcare intelligence suite aimed at large‑scale automation and analytics.

How much revenue growth does TIRX expect from its AI business by 2027 (TIRX)?

Analysts project about a 300% year‑over‑year increase in AI-related revenue by 2027. According to the company, this growth stems from enterprise AI deployments across insurance, brokers, and adjacent healthcare analytics.

What efficiency gains does the TIRX AI Strategic Initiative claim for operations (TIRX)?

The company claims the autonomous operations platform can cut operational costs by 40% or more. According to the company, gains come from zero‑human‑intervention workflows, self‑optimization, and predictive maintenance.

What performance metrics does TIRX cite for its AI and healthcare offerings (TIRX)?

TIRX cites 90% automation of routine knowledge work and a healthcare suite with 95% accuracy. According to the company, metrics are based on custom models and integrated real‑time data sources.